vinorelbine tartrate
Pharmaranks rates Vinorelbine Tartrate 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Vinorelbine Tartrate is a vinca alkaloid used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease, Ovarian Neoplasms.
Vinca Alkaloid · by Rising
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Vinorelbine Tartrate
- Drug class
- Vinca Alkaloid
- Form
- Injectable
- Strength
- Vinorelbine Tartrate EQ 10MG BASE/ML
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- Manufacturer
- Rising
- FDA application
- ANDA200148
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Vinorelbine Tartrate treat?
- Vinorelbine Tartrate (Vinorelbine Tartrate) may be used to treat breast neoplasms, non-small-cell lung carcinoma, hodgkin disease, ovarian neoplasms, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Vinorelbine Tartrate rated?
- pharmaranks gives Vinorelbine Tartrate a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Vinorelbine Tartrate?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vinorelbine Tartrate. To pay less, Vinorelbine Tartrate is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Vinorelbine Tartrate?
- Vinorelbine Tartrate is marketed by Rising. You can see Rising's full profile, rating, and other products on pharmaranks.
- Is Vinorelbine Tartrate a brand-name or generic drug?
- Vinorelbine Tartrate is a generic medication; its active ingredient is Vinorelbine Tartrate. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Vinorelbine Tartrate available over the counter?
- No. Vinorelbine Tartrate is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Vinorelbine Tartrate come in?
- Vinorelbine Tartrate is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Vinorelbine Tartrate?
- Vinorelbine Tartrate is classified as vinca alkaloid, per the FDA's Established Pharmacologic Class.
- Is Vinorelbine Tartrate FDA-registered?
- Vinorelbine Tartrate is on record with the U.S. FDA under application number ANDA200148. You can verify this on its official FDA label.
- Has Vinorelbine Tartrate been recalled by the FDA?
- Vinorelbine Tartrate has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Vinorelbine Tartrate safe?
- There's no single safe-or-not verdict. pharmaranks gives Vinorelbine Tartrate a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
emrelis
Telisotuzumab Vedotin-Tllv
exemestane
Exemestane
gilotrif
Afatinib Dimaleate
hernexeos
Zongertinib
idarubicin hydrochloride
Idarubicin Hydrochloride
kanjinti
Trastuzumab-Anns
Compare Vinorelbine Tartrate head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
vinorelbine tartrate
72/100